Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Licenses Rosetta Resolver Gene Expression System

NEW YORK, Dec 29 – Paradigm genetics has licensed the Rosetta Resolver gene expression analysis system from Rosetta Inpharmatics and Agilent Technologies, the companies announced Friday.

The companies did not disclose the financial terms of the agreement. Agilent has been the exclusive distributor of the Rosetta Resolver, a bioinformatics gene expression analysis system that can be used with a variety of microarrays, since December 1999.

Rosetta has previously licensed the Resolver, which it launched in its newest version October 3, to Glaxo Wellcome and the Harvard Center for Genomics Research. Rosetta also recently opened a new gene expression profiling facility in Bothell, Wash.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.